Načítá se...
Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer
Everolimus combined with exemestane is an important treatment option for patients suffering from estrogen receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer (ABC) who have been previously treated with a nonsteroidal aromatase inhibitor (NSAI). After presenta...
Uloženo v:
| Vydáno v: | Breast Cancer (Auckl) |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Libertas Academica
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5214808/ https://ncbi.nlm.nih.gov/pubmed/28096680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BCBCR.S12443 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|